Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02725684 · ClinicalTrials.gov registry record
Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
A clinical trial, sponsored by Rockefeller University.
- Completed
- Registry status
- 36
- Enrollment target
NCT02725684 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 36 participants.
The verdict
NCT02725684 has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether the use of genomics can help identify patient specific treatment choices in cancer. In order to test this, the investigators plan to use genomic sequencing technology to identify patient specific mutations in glioblastoma multiforme (GBM) as compared to normal cells to identify mutations. Further analysis will identify potential treatment targets and whether there are any drugs that could be used for these particular mutations. Follow up clinical data will be assessed to see if this individualized method of choosing treatment options can improve clinical outcomes in patients with GBM.
Interventions
- OTHER Observational study, no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2015-03-12 |
| Est. Completion | 2017-07-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02725684
The ClinicalTrials.gov registry entry for NCT02725684 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational study, no intervention is the first listed.
NCT02725684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02725684 about?
NCT02725684 is a clinical study titled "Using Genomic Analysis to Guide Individual Treatment in Glioblastoma". The purpose of this study is to assess whether the use of genomics can help identify patient specific treatment choices in cancer. In order to test this, the investigators plan to use genomic sequencing technology to identify patient specific mutations in glioblastoma multiforme (GBM) as compared to...
What is the current status of trial NCT02725684?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2015-03-12. Estimated completion is 2017-07-07.
What interventions are being tested in trial NCT02725684?
The interventions under investigation include: Observational study, no intervention (OTHER).
Who is sponsoring clinical trial NCT02725684?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.